Research toward malaria vaccines.
Malaria exacts a toll of disease to people in the Tropics that seems incomprehensible to those only familiar with medicine and human health in the developed world. The methods of molecular biology, immunology, and cell biology are now being used to develop an antimalarial vaccine. The Plasmodium parasites that cause malaria have many stages in their life cycle. Each stage is antigenically distinct and potentially could be interrupted by different vaccines. However, achieving complete protection by vaccination may require a better understanding of the complexities of B- and T-cell priming in natural infections and the development of an appropriate adjuvant for use in humans.
D000953:Antigens, Protozoan / Q000032:analysis; D001179:Arthropod Vectors; D000939:Epitopes / Q000032:analysis; D004912:Erythrocytes / Q000469:parasitology; D006801:Humans; D007167:Immunotherapy; D008288:Malaria / Q000276:immunology / Q000517:prevention & control* / Q000635:transmission; D008970:Molecular Weight; D009032:Mosquito Control; D010961:Plasmodium / Q000276:immunology; D011948:Receptors, Antigen, T-Cell / Q000276:immunology; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology; D014612:Vaccines
D000953:Antigens, Protozoan; D000939:Epitopes; D011948:Receptors, Antigen, T-Cell; D014612:Vaccines